Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
LGV.WS was delisted on the 6th of December, 2022.
33 hedge funds and large institutions have $6.33M invested in Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$536K |
| 2 |
Blackstone Inc
New York
|
+$427K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$402K |
| 4 |
NFAM
North Fourth Asset Management
Englewood Cliffs,
New Jersey
|
+$340K |
| 5 |
SC
Sculptor Capital
New York
|
+$339K |
Top Sellers
LGV.WS Hedge Fund Activity: Q2 2021 in Review
33 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (LGV.WS) for Q2 2021, worth a combined $6.33M.
Buyers outnumbered sellers: 33 funds opened new LGV.WS positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HealthCor Management, opening a new position worth an estimated $536K.
- 33 institutional investors held Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (LGV.WS) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $6.33M of Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share stock for Q2 2021.
- 33 funds opened new Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share positions in Q2 2021 and 0 closed out, a net change of +33 holders.
- The largest Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share buyer in Q2 2021 was HealthCor Management, an estimated $536K added.
Based on aggregated 13F filings for Q2 2021.